Boston Scientific Expands Share Buyback by $4 Billion, Adds Two Directors
MT Newswires Live
Feb 24
Boston Scientific (BSX) said late Monday its board authorized an additional $4 billion in share repurchases, raising the company's total buyback capacity to $5 billion.
Separately, the company said it expanded its board to 12 members and appointed Catherine Smith and Christophe Weber as directors.
Smith will serve on the Audit Committee and the Nominating and Governance Committee, while Weber will join the Executive Compensation and Human Resources Committee and the Risk, Science and Technology Committee, it added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.